Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 76: 902-908, 1994;
8750-7587/94 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Desai, P. M.
Right arrow Articles by Murray, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Desai, P. M.
Right arrow Articles by Murray, P. A.

Journal of Applied Physiology, Vol 76, Issue 2 902-908, Copyright © 1994 by American Physiological Society

ARTICLES

Humoral pulmonary vasoregulation in conscious dogs after left lung autotransplantation

P. M. Desai, K. Nishiwaki, R. S. Stuart, D. P. Nyhan and P. A. Murray
Division of Cardiac Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287-4961.

We investigated the roles of cyclooxygenase metabolites, arginine vasopressin (AVP) and angiotensin II (ANG II), as mediators of the chronic increase in pulmonary vascular resistance associated with left lung autotransplantation (LLA) in conscious dogs. Continuous left pulmonary vascular pressure-flow (LP-Q) plots were generated in conscious dogs 2- to 5-wk post-LLA and in sham-operated control conscious dogs. LLA resulted in a marked shift (P < 0.01) in the LP-Q relationship as reflected by an approximate doubling of the pulmonary vascular pressure gradient at each common value of left pulmonary blood flow compared with the control group. Cyclooxygenase pathway inhibition (indomethacin) and AVP V1-receptor block had no effect on the LP-Q relationship post-LLA. Angiotensin-converting enzyme inhibition (captopril) also failed to reverse the increase in pulmonary vascular resistance post-LLA. Because captopril has the dual effect of inhibiting the production of ANG II and the degradation of bradykinin, additional studies utilizing a selective ANG II receptor antagonist were performed. ANG II receptor block (saralasin) significantly altered the LP-Q relationship post-LLA to cause active pulmonary vasodilation (P < 0.01). Thus, the chronic increase in pulmonary vascular resistance post-LLA is not mediated by metabolites of the cyclooxygenase pathway or AVP V1-receptor activation. A significant component of the increase in pulmonary vascular resistance resulting from LLA is mediated by ANG II. The differential responses to captopril and saralasin may imply a pulmonary vasoregulatory role for bradykinin post-LLA.


This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
S. Doi, N. Smedira, and P. A. Murray
Pulmonary vasoregulation by endothelin in conscious dogs after left lung transplantation
J Appl Physiol, January 1, 2000; 88(1): 210 - 218.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. Seki, N. A. Flavahan, N. G. Smedira, and P. A. Murray
Superoxide anion scavengers restore NO-mediated pulmonary vasodilation after lung transplantation
Am J Physiol Heart Circ Physiol, January 1, 1999; 276(1): H42 - H46.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
K. Yoshida, N. A. Flavahan, M. Horibe, N. G. Smedira, and P. A. Murray
Endothelial defect mediates attenuated vasorelaxant response to isoproterenol after lung transplantation
Am J Physiol Heart Circ Physiol, January 1, 1999; 276(1): H159 - H166.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online